Tuesday, June 29, 2021

Novartis, GBT sickle cell drugs face coverage hurdles as gene therapy threats loom: survey

That's not to mention potential gene therapy threats. For both Adakveo and Oxbryta, 64% of physicians said the drugs have unfavorable cost and ...

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...